Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypercapnia | 1 | 2018 | 172 | 0.64 | Why? |
| Extracorporeal Circulation | 1 | 2018 | 130 | 0.62 | Why? |
| Teicoplanin | 3 | 2021 | 191 | 0.55 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2017 | 260 | 0.54 | Why? |
| Carbon Dioxide | 2 | 2018 | 917 | 0.45 | Why? |
| Hypoalbuminemia | 2 | 2020 | 235 | 0.35 | Why? |
| Acinetobacter baumannii | 2 | 2021 | 378 | 0.31 | Why? |
| Respiratory Insufficiency | 2 | 2017 | 7301 | 0.31 | Why? |
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 5002 | 0.28 | Why? |
| Noninvasive Ventilation | 1 | 2018 | 2329 | 0.28 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3832 | 0.27 | Why? |
| Klebsiella pneumoniae | 2 | 2020 | 658 | 0.26 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.25 | Why? |
| beta-Lactamases | 2 | 2020 | 759 | 0.25 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.24 | Why? |
| Vascular Diseases | 2 | 2020 | 846 | 0.22 | Why? |
| Acinetobacter Infections | 2 | 2021 | 273 | 0.22 | Why? |
| Klebsiella Infections | 3 | 2020 | 466 | 0.22 | Why? |
| NADPH Oxidase 2 | 1 | 2020 | 58 | 0.21 | Why? |
| Platelet Aggregation | 1 | 2021 | 318 | 0.18 | Why? |
| Bacteremia | 2 | 2020 | 1372 | 0.18 | Why? |
| PTEN Phosphohydrolase | 1 | 2017 | 70 | 0.17 | Why? |
| Thrombophlebitis | 1 | 2018 | 94 | 0.17 | Why? |
| Candidemia | 2 | 2020 | 353 | 0.17 | Why? |
| Thrombin | 1 | 2020 | 325 | 0.17 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.16 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.16 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.15 | Why? |
| Pneumonia, Ventilator-Associated | 2 | 2021 | 861 | 0.15 | Why? |
| Superinfection | 1 | 2020 | 459 | 0.15 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2020 | 398 | 0.15 | Why? |
| Energy Intake | 1 | 2017 | 323 | 0.14 | Why? |
| Adrenomedullin | 1 | 2017 | 217 | 0.14 | Why? |
| Lipopolysaccharide Receptors | 1 | 2017 | 357 | 0.14 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.14 | Why? |
| Cross Infection | 3 | 2021 | 8675 | 0.14 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2021 | 2963 | 0.14 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.13 | Why? |
| Respiratory Mechanics | 1 | 2018 | 585 | 0.13 | Why? |
| Nutritional Support | 1 | 2017 | 447 | 0.12 | Why? |
| Intensive Care Units | 9 | 2021 | 29594 | 0.12 | Why? |
| Ozone | 1 | 2020 | 757 | 0.12 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.12 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.11 | Why? |
| Staphylococcal Infections | 1 | 2020 | 1099 | 0.11 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.11 | Why? |
| Peptide Fragments | 2 | 2020 | 2075 | 0.10 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.10 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Coronary Artery Disease | 1 | 2021 | 2570 | 0.08 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.08 | Why? |
| Renal Insufficiency, Chronic | 1 | 2020 | 2654 | 0.08 | Why? |
| Prone Position | 1 | 2017 | 1861 | 0.08 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Aged | 15 | 2021 | 215776 | 0.07 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.07 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.07 | Why? |
| Humans | 29 | 2021 | 930598 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Male | 20 | 2021 | 367725 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Female | 19 | 2021 | 380317 | 0.06 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.06 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Agglutination | 1 | 2021 | 17 | 0.06 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.06 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2021 | 1115 | 0.06 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.05 | Why? |
| Platelet Function Tests | 1 | 2021 | 231 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Albumins | 1 | 2020 | 324 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2021 | 17020 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Catheter-Related Infections | 1 | 2021 | 381 | 0.04 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Pseudomonas Infections | 1 | 2020 | 425 | 0.04 | Why? |
| Italy | 4 | 2020 | 38444 | 0.04 | Why? |
| Colistin | 1 | 2018 | 217 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Multimorbidity | 1 | 2020 | 703 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Metabolic Diseases | 1 | 2020 | 505 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2021 | 7972 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 711 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Risk Management | 1 | 2021 | 1044 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.03 | Why? |
| Probiotics | 1 | 2020 | 694 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.03 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Oxidative Stress | 1 | 2020 | 2050 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Dietary Supplements | 1 | 2020 | 2251 | 0.02 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Alessandri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(182)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_